Telemedicine (mobile-Health) as an alternative in the follow-up of patients in a randomized clinical trial for the treatment of cutaneous leishmaniasis in the state of Amazonas, Brazil
Authors:
- Silmara Navarro PenniniSPSilmara Navarro Pennini
- Jorge Augusto de Oliveira GuerraJGJorge Augusto de Oliveira Guerra
- Paula Frassinetti Bessa RebelloPRPaula Frassinetti Bessa Rebello
- Marília Rosa Abtibol-BernardinoMAMarília Rosa Abtibol-Bernardino
- Amanda Canto DuarteADAmanda Canto Duarte
- Higor Marques de QueirozHQHigor Marques de Queiroz
- Anette Chrusciak-TalhariACAnette Chrusciak-Talhari
- Maria das Graças Vale Barbosa GuerraMGMaria das Graças Vale Barbosa Guerra
- Sinésio TalhariSTSinésio Talhari
Open Access
- 9 January 2025
- journal article
- case report
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 100 (2) , 355-357
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Store-and-forward teledermatology in a Spanish health area significantly increases access to dermatology expertiseBMC Primary Care, 2024
- Treatment of cutaneous leishmaniasis with a sequential scheme of pentamidine and tamoxifen in an area with a predominance of Leishmania (Viannia) guyanensis: A randomised, non‐inferiority clinical trialTropical Medicine & International Health, 2023
- mHealth Monitoring of Treatment of Cutaneous Leishmaniasis Patients: A Community-Based Implementation StudyThe American Journal of Tropical Medicine and Hygiene, 2023
- The Impact of COVID‐19 on the Initiation of Clinical Trials in Europe and the United StatesClinical Pharmacology & Therapeutics, 2022
- WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID‐19): from bedside to phone‐sideClinical and Experimental Dermatology, 2020
- Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluationPLOS Neglected Tropical Diseases, 2018
- Smartphone usage in the 21st century: who is active on WhatsApp?BMC Research Notes, 2015
- Estudo clínico randomizado comparando antimoniato de meglumina, pentamidina e anfotericina B para o tratamento da leishmaniose cutânea ocasionada por Leishmania guyanensisAnais Brasileiros de Dermatologia, 2011